Literature DB >> 18330076

Burden of hospitalizations due to Rotavirus infection in Emilia Romagna, Italy.

Giovanni Gabutti1, Claudio Lazzara, Maria Marsella, Mauro Bergamini, Cristina Malaventura, Caterina Borgna-Pignatti.   

Abstract

The aim of this study was to collect data on hospitalizations due to gastrointestinal diseases, in particular Rotavirus gastroenteritis (RVGE), in the Region of Emilia Romagna, Italy. The national hospital discharge database was used to evaluate the epidemiology of RV infections in the 2000-2003 period, analyzing only the principal diagnosis. The available age groups were 0-14 years, 15-64 years and, >64 years. Hospitalization related costs were estimated through Diagnosis Related Group (DRG) rates even though a specific DRG for RVGE does not exist. In the 0-14yr. old subjects, RV were responsible for an average of 310 GE-related hospitalizations per year and globally represented 17% of admissions for enteritis and 84% of hospitalized viral GE. Fifty-six percent of the enteritis was of undefined origin. Considering the three possible DRG codes to which the disease can be referred (184, 298, 422) and the classification of hospitals in two categories, the cost of each admission for RVGE ranged between 1,293.83 Euro and 2,263.79 Euro. RV seems to play an important role as a cause of severe viral gastroenteritis, although RV infections are certainly underestimated for several reasons, one of them being the low sensitivity of hospital discharge forms. Today we have safe and effective vaccines that can be used in order to protect from moderate/severe forms of RV-related diarrhea. The extensive use of these vaccines could reduce hospitalizations and related costs in industrialized countries.

Entities:  

Mesh:

Year:  2007        PMID: 18330076

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  6 in total

1.  The cost-effectiveness of rotavirus vaccination in Malawi.

Authors:  Stephen A Berry; Benjamin Johns; Chuck Shih; Andrea A Berry; Damian G Walker
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

2.  Hospitalisation for rotavirus gastroenteritis in the paediatric population in the Veneto Region, Italy.

Authors:  Mario Saia; Aurore Giliberti; Giampietro Callegaro; Tatjana Baldovin; Marta Cecilia Busana; Francesco Pietrobon; Chiara Bertoncello; Vincenzo Baldo
Journal:  BMC Public Health       Date:  2010-10-22       Impact factor: 3.295

3.  Epidemiology of rotavirus-associated hospital admissions in the province of Ferrara, Italy.

Authors:  Maria Marsella; Licia Raimondi; Mauro Bergamini; Monica Sprocati; Ettore Bigi; Vincenzo De Sanctis; Caterina Borgna-Pignatti; Giovanni Gabutti
Journal:  Eur J Pediatr       Date:  2009-03-03       Impact factor: 3.183

4.  Hospitalizations associated with rotavirus gastroenteritis in Spain, 2001-2005.

Authors:  Ana López-de-Andrés; Rodrigo Jiménez-García; Pilar Carrasco-Garrido; Alejandro Alvaro-Meca; Patricia Graciela Galarza; Angel Gil de Miguel
Journal:  BMC Public Health       Date:  2008-04-08       Impact factor: 3.295

5.  Temporal trends in hospitalization for rotavirus gastroenteritis: A nationwide study in Italy, 2005-2012.

Authors:  Antonella Mattei; Margherita Sbarbati; Fabiana Fiasca; Anna Maria Angelone; Maria Chiara Mazzei; Ferdinando di Orio
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

6.  Fourteen years' clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy.

Authors:  Paolo Bonanni; Giorgio Conforti; Elisabetta Franco; Giovanni Gabutti; Federico Marchetti; Antonella Mattei; Rosa Prato; Giovanni Vitali Rosati; Francesco Vitale
Journal:  Hum Vaccin Immunother       Date:  2021-08-09       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.